How major markets typically perform in the 100 days before a presidential election
Bank of America lays out what could be in store for financial markets in the next 100 days.
Stellantis to offer broad buyouts to U.S. salaried workers, warns of possible layoffs
The automaker, which reported disappointing first-half results, said that if not enough its employees take buyouts, involuntary terminations could follow.
The key price support levels to watch as sellers return to Nvidia
Todd Gordon breaks down the charts in the one-time AI darling getting hit big this month.
CrowdStrike shares plunge 9.7% to lowest level of the year on report that Delta may seek damages
CrowdStrike shares fell after CNBC reported on Monday that Delta hired an attorney to seek compensation following the July 19 global IT outage.
Bella Hadid ‘shocked’ at ‘lack of sensitivity’ in Adidas ad campaign linked to 1972 Munich Olympics
Hadid said that she was not aware of the historical events of the 1972 Munich Olympics, and that she would not have taken part in the campaign had she known.
Russia approves law allowing use of crypto for global payments as it faces ongoing sanctions
Russian lawmakers on Tuesday approved a new that permits international payments via cryptocurrencies.
Google parent Alphabet’s partnership with AI firm Anthropic under investigation in the UK
The U.K.’s Competition and Markets Authority said that it is investigating Google parent Alphabet’s partnership with artificial intelligence startup Anthropic.
Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs
The results come as Pfizer scrambles to stabilize its business and win back Wall Street’s favor following the rapid decline in demand for its Covid products.
Air New Zealand becomes first major airline to scrap its 2030 climate goal
Air New Zealand on Tuesday dropped its 2030 climate goal, citing delivery delays of fuel-efficient aircraft and the affordability of alternative jet fuels.
Merck shares fall 9% despite earnings beat, strong demand for top drugs like Keytruda
The drugmaker raised its full-year sales forecast to $63.4 billion to $64.4 billion on increased demand for key products, particularly oncology treatments.
